SYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…
Active Pharmaceutical Ingredients (API)
-
-
Mepolizumab
GlaxoSmithKline`s Nucala (Mepolizumab) gets European Approval for use in Three Additional Eosinophil-driven Diseases.
by adminby adminKEYPOINTS: GlaxoSmithKline (NYSE:GSK) announces that the European Commission has approved Nucala (Mepolizumab), a monoclonal antibody that targets interleukin-5, for use in three…
-
Active Pharmaceutical Ingredients (API)Risankizumab
European Commission approves AbbVie’s Skyrizi (Risankizumab) to Treat Adults with Active Psoriatic Arthritis.
by adminby adminKEYPOINTS: AbbVie announces that the European Commission (EC) has approved SKYRIZI (Risankizumab, 150 mg, subcutaneous injection at week 0, week 4, and…
-
Active Pharmaceutical Ingredients (API)Insulin
Biocon Biologics and Viatris launch Interchangeable Biosimilars SEMGLEE and Insulin Glargine Injection in US.
by adminby adminKEYPOINTS: Biocon Biologics and Viatris Inc have launched Semglee (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an…
-
Active Pharmaceutical Ingredients (API)Ronapreve & Regkirona
EMA Recommends Authorisation of Two Monoclonal Antibody Medicines Ronapreve & Regkirona for Covid-19
by adminby adminTwo monoclonal antibody medicines for treating COVID-19 have been recommended for authorisation by the European Medicines Agency on Thursday (11 November), sparking…
-
Levodopa and Entacapone
STADA and Bioglan signed an Agreement to Increase Production Capacity to Meet Rising Demand for Parkinson’s Treatment.
by adminby adminKEYWORDS: Bioglan, the Swedish subsidiary of the Spanish pharmaceutical company, and STADA Arzneimittel AG have signed an agreement to expand the production…
-
Ropeginterferon
FDA Approves Ropeginterferon Alfa-2b-njft (Besremi) Treatment for Rare Blood Disease Polycythemia Vera (PV).
by adminby adminSUMMARY: PharmaEssentia Corporation a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in…
-
Active Pharmaceutical Ingredients (API)Metformin
DawaaDost announces one day’s Diabetes Course of ‘Metformin 1000 mg’ at only rupee one per day.
by adminby adminKEYPOINTS: In this programme, DawaaDost will retail Metformin 1000 mg tablets from the top 10 pharmaceutical companies in the country. One in…
-
Active Pharmaceutical Ingredients (API)COVAXIndia
Serum Institute looks to supply 25 million doses to Covax till December
by adminby adminPune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…
-
Active Pharmaceutical Ingredients (API)PAXLOVID
Pfizer prepares to Launch COVID-19 Oral Antiviral Pill Reduced Risk of Hospitalization or Death by 89% in Interim Analysis.
by adminby adminKEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…